The Biological Effects of Interleukin-6 and Their Clinical Applications in Autoimmune Diseases and Cancers
Journal Title: Rheumatica Acta: Open Access - Year 2017, Vol 1, Issue 1
Abstract
Interleukin-6 (IL-6) is one of the pro-inflammatory cytokines involved in pathogenesis of various autoimmune and chronic inflammatory diseases. IL-6 through binding to its cellular receptor can transduce both classical- and trans-signaling pathways. Overproduction of circulating IL-6 can be detected in patients with different autoimmune diseases. Tocilizumab, a humanized monoclonal antibody against IL-6 receptor, can block IL-6-mediated signaling and has been approved for the treatment of rheumatoid arthritis and Castleman’s disease. Besides, expression of IL-6 may promote tumorigenesis and has been detected in various tumors, including multiple myeloma, colorectal cancer, breast cancer, lymphoma, breast cancer and lung cancer. Furthermore, increased levels of circulating IL-6 are associated with poor prognosis and cachexia in cancer patients. Monotherapy with IL-6 blockade or a combination therapy with both IL-6 blockade and conventional chemotherapy may reduce the progression of cancer and improve the status of cachexia in cancer patients.
Authors and Affiliations
Yang Deng-Ho
Eosinophilic Fasciitis in a Patient with Hepatitis C Virus Infection: Coincidence or Association?
Eosinophilic fasciitis is a rare connective tissue disease characterized by symmetrical and painful swelling with a progressive induration and thickening of the skin and soft tissues. Its etiology is unknown, but possibl...
Septic Arthritis: The drainage controversy
Objective: Septic arthritis is a relatively rare disease, which is associated with a high morbidity and mortality. Treatment consists of prolonged antibiotic therapy and removal of intra-articular inflammatory debris. Ho...
The Complexity of DNA Transcends Epigenetics
Availability of new has afforded rheumatologists the opportunity to investigate molecular pathophysiology of joint disease techniques [1,2]. Attempts to relate DNA polymorphisms to disease activity or addresses one aspec...
Idiopathic Intracranial Hypertension: Neuropsychiatric Systemic Lupus Erythematosus or Gonadotropin- releasing hormone agonist side effect?
A 31-year-old systemic lupus erythematotus (SLE) patient presented with headache and blurring of vision. Prior to this, she received 2 doses of monthly triptorelin for endometriosis. On examination, she had bilateral six...
Remission of Glucocorticoid-Resistant Polymyalgia Rheumatica achieved with Tocilizumab: 2 Case Reports
Polymyalgia rheumatica (PMR) is an idiopathic inflammatory disease characterized by pain and stiffness around the shoulders, neck and hips. IL-6 is an important cytokine in the pathogenesis of the disease. Although gluco...